phage TMP sequences in fecal samples as predictive biomarkers for favorable immunotherapy outcomes, likely through molecular mimicry between TMP epitopes and the tumor-associated antigen GPD1-L that enhances anti-tumor immune recognition (Fluckiger et al., 2020; Li et al., 2024). The gene discussed is GPD1; the disease is neoplasm.